Therapy of Non-Dermatophytic Mycoses in Animals
AbstractThis review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism (Cryptococcus spp. and Malassezia pachydermatis). View Full-Text
Share & Cite This Article
Elad, D. Therapy of Non-Dermatophytic Mycoses in Animals. J. Fungi 2018, 4, 120.
Elad D. Therapy of Non-Dermatophytic Mycoses in Animals. Journal of Fungi. 2018; 4(4):120.Chicago/Turabian Style
Elad, Daniel. 2018. "Therapy of Non-Dermatophytic Mycoses in Animals." J. Fungi 4, no. 4: 120.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.